ALPHA TAU MEDICAL LTD (DRTS) Stock Price, Quote, News and Overview
NASDAQ:DRTS - Nasdaq - IL0011839383 - Common Stock - Currency: USD
DRTS Quote, Performance and Key Statistics
NASDAQ:DRTS (8/1/2025, 8:00:00 PM)
2.98
-0.09 (-2.93%)
The current stock price of DRTS is 2.98 USD. In the past month the price decreased by -5.99%. In the past year, price increased by 41.23%.
DRTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.98 | 221.46B | ||
| ISRG | INTUITIVE SURGICAL INC | 60.01 | 173.19B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.25 | 155.95B | ||
| SYK | STRYKER CORP | 29.4 | 144.38B | ||
| MDT | MEDTRONIC PLC | 16.24 | 114.47B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 50.55B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.87 | 46.53B | ||
| IDXX | IDEXX LABORATORIES INC | 46.98 | 43.07B | ||
| RMD | RESMED INC | 29.24 | 40.94B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.99 | 31.98B | ||
| DXCM | DEXCOM INC | 46.64 | 31.09B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.13 | 25.48B |
Related stock screener links
About DRTS
Company Profile
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
Company Info
ALPHA TAU MEDICAL LTD
Kiryat Hamada 5
JERUSALEM IL
Employees: 121
Phone: 97235774115
ALPHA TAU MEDICAL LTD / DRTS FAQ
What is the stock price of ALPHA TAU MEDICAL LTD today?
The current stock price of DRTS is 2.98 USD. The price decreased by -2.93% in the last trading session.
What is the ticker symbol for ALPHA TAU MEDICAL LTD stock?
The exchange symbol of ALPHA TAU MEDICAL LTD is DRTS and it is listed on the Nasdaq exchange.
On which exchange is DRTS stock listed?
DRTS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ALPHA TAU MEDICAL LTD stock?
10 analysts have analysed DRTS and the average price target is 8.93 USD. This implies a price increase of 199.5% is expected in the next year compared to the current price of 2.98. Check the ALPHA TAU MEDICAL LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ALPHA TAU MEDICAL LTD worth?
ALPHA TAU MEDICAL LTD (DRTS) has a market capitalization of 252.41M USD. This makes DRTS a Micro Cap stock.
How many employees does ALPHA TAU MEDICAL LTD have?
ALPHA TAU MEDICAL LTD (DRTS) currently has 121 employees.
What are the support and resistance levels for ALPHA TAU MEDICAL LTD (DRTS) stock?
ALPHA TAU MEDICAL LTD (DRTS) has a support level at 2.92 and a resistance level at 3. Check the full technical report for a detailed analysis of DRTS support and resistance levels.
Should I buy ALPHA TAU MEDICAL LTD (DRTS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DRTS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DRTS, evaluating the profitability, health, valuation and growth aspects
- ALPHA TAU MEDICAL LTD (DRTS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ALPHA TAU MEDICAL LTD (DRTS) Sales and EPS estimates to see what analysts future expectations are.
- ALPHA TAU MEDICAL LTD (DRTS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ALPHA TAU MEDICAL LTD (DRTS) Insider and Institutional Ownership to learn about the owners and their transactions.
- ALPHA TAU MEDICAL LTD (DRTS) Stock Chart to make your own analysis
- ALPHA TAU MEDICAL LTD (DRTS) Latest news and press-releases to stay up to date.
Does ALPHA TAU MEDICAL LTD (DRTS) stock pay dividends?
DRTS does not pay a dividend.
When does ALPHA TAU MEDICAL LTD (DRTS) report earnings?
ALPHA TAU MEDICAL LTD (DRTS) will report earnings on 2025-08-21, after the market close.
What is the Price/Earnings (PE) ratio of ALPHA TAU MEDICAL LTD (DRTS)?
ALPHA TAU MEDICAL LTD (DRTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.46).
What is the Short Interest ratio of ALPHA TAU MEDICAL LTD (DRTS) stock?
The outstanding short interest for ALPHA TAU MEDICAL LTD (DRTS) is 0.16% of its float. Check the ownership tab for more information on the DRTS short interest.
DRTS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to DRTS. When comparing the yearly performance of all stocks, DRTS is one of the better performing stocks in the market, outperforming 86.6% of all stocks.
DRTS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DRTS. The financial health of DRTS is average, but there are quite some concerns on its profitability.
DRTS Financial Highlights
Over the last trailing twelve months DRTS reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS decreased by -12.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -36.83% | ||
| ROE | -50.67% | ||
| Debt/Equity | 0.09 |
DRTS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to DRTS. The Buy consensus is the average rating of analysts ratings from 10 analysts.